Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical Applicability - European Urology
Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma
IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues
Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma - Document - Gale OneFile: Health and Medicine
IMP3 - an overview | ScienceDirect Topics
Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2* - Journal of Biological Chemistry
High insulin‐like growth factor mRNA‐binding protein 3 (IMP3) protein expression is associated with poor survival in muscle‐invasive bladder cancer - Szarvas - 2012 - BJU International - Wiley Online Library
USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER - diagram, schematic, and image 06
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis | BMC Gastroenterology | Full Text
The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions - Fertility and Sterility
Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome | Journal of Medical Genetics
IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues
PDF) IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression | Modern Pathology
The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes - ScienceDirect
The Oncofetal Protein IMP3: A Useful Marker to Predict Poor Clinical Outcome in Neuroendocrine Tumors of the Lung - Journal of Thoracic Oncology
USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER - diagram, schematic, and image 03
IMP3 (RM) - Biocare Medical
PDF) Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma
Cancers | Free Full-Text | IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma | HTML
USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER - diagram, schematic, and image 02
HellermannTyton 151-42359 IMP3.5 PA66 WH 100 Lead marker Writing area: 88.9 x 19.1 mm White 1 pc(s) | Conrad.com
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis | BMC Gastroenterology | Full Text
Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2* - Journal of Biological Chemistry
USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER - diagram, schematic, and image 04
Cancers | Free Full-Text | IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma | HTML
